Matrix Capital Management Company, LP

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$161.89M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Matrix Capital Management Company, LP

According to the SEC Form 4 filings, Matrix Capital Management Company, LP, being in a position of

  1. 10 percent owner at Aura Biosciences, Inc.,
    оver the last 12 months, has bought 1560000 shares for $14.04M, and sold 0 shares,
    over all time since 2021-11-02, has bought 4595000 shares for $54.03M, and sold 0 shares.

The largest purchase of all time was on 2023-06-20 and amounted to 4760000 shares of Zentalis Pharmaceuticals, Inc. for $107.86M.

Biography of Matrix Capital Management Company, LP

No biography is available at this moment.

2023-11-09PurchaseAura Biosciences, Inc.
AURA
10 percent owner
1.56M
5.251%
$9.00$14.04M+13.85%
2023-06-20PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
4.76M
6.3802%
$22.66$107.86M-48.63%
2022-12-05PurchaseAura Biosciences, Inc.
AURA
director
1.25M
4.0472%
$12.00$15M-16.68%
2021-11-02PurchaseAura Biosciences, Inc.
AURA
director
1.78M
28.1409%
$14.00$24.99M-1.39%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.